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The  mechanisms  by  which  intravenously  injected  Bordetella  pertussis  organisms 
provoke striking lymphocytosis in mice are  incompletely understood.  The primary 
increase in blood lymphocytes is not due to newly formed cells, but to mature-appear- 
ing small lymphocytes that do not incorporate previously injected tritiated thymidine 
(1).  Also, there is depletion of small lymphocytes from the lymph nodes, spleen,  and 
thymus of mice during B. pertussis-induced  lymphocytosis, suggesting that the cells 
in the blood may have been displaced from these organs (2).  It has not been deter- 
mined whether the principal locus of action of pertussis is on the blood lymphocytes 
or on the lymphoid organs through which they recirculate;  nor has it been clarified 
how pertussis brings about the redistribution of lymphoid cells. 
Recent  studies  from  this  laboratory  have  emphasized  the  relevance  of 
changes in  lymphocyte distribution  in  draining  lymph nodes  to the  action of 
locally  injected  immunologic  adjuvants,  such  as  B.  pertussis  (3,  4).  It  was 
shown that B. pertussis  organisms may indirectly influence lymphocyte traffic 
in  the  draining  lymph  node  by  affecting  reticuloendothelial  elements  in  the 
paracortical  zone of the node  (4,  5).  The present  studies  deal with  the direct 
effects of B. pertussis organisms and culture supernatant fluids on lymphocytes 
and their recirculatory properties. 
Materials and Methods 
Pertussls  Organisms  and  Culture Supernatant  Fluids.--Suspensions  of  killed Bordetella 
pertussis organisms in saline were obtained from Glaxo Ltd., London, England, washed twice 
with saline, and resuspended at a concentration of 5 X  109 organisms/ml. Supernatant  fluids 
from B. pertussis cultures  (BPCS)  1 were harvested after growth in liquid culture  medium as 
described previously (6). 
* Aided in part by grants CA-12827-01 and AI-06116. 
:~ Robert N. Taub is a Scholar of the Leukemia Society of America, Inc. 
1 Abbreviations used in this paper: BPCS,  B. pertussis cultures;  LPF, lymphocytosls-pro- 
moting factor. 
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Mice.~3-month old male CBA/J mice, obtained from the Jackson Laboratory, Bar Harbor, 
Maine, were used both as donors and recipients of radioactively labeled lymphoid cells. 
Thoracic  Duct Cannulation.--Performed by the method of Morse and Riester (7). 
Preparation of Cell Suspensions and Radiolabding.--Single-cell suspensions of mouse lymph 
node cells were obtained by pressing the lymph nodes of donor mice through nylon mesh and 
filtering through cotton wool as described previously (8). Thoracic duct cells were collected 
overnight in heparinized minimal Eagle's medium. Thrice washed cell suspensions were incu- 
bated with sodium  chromate Cr-51  (Radiochemical Center,  Amersham-Searle Corp.,  Des 
Plains, Ill., specific activity 5 mCi/mg) at a concentration of 10 #Ci/10 s cells for 30 rain at 
37°C. The suspensions were then washed three times and injected intravenously in dosages of 
1.0-1.5  M  107  cells in a  volume of 0.5  ml into each of three or more recipients per group. 
18 hr later, the recipients were killed  and  samples of  the "peripheral"  (brachial,  axillaly, 
inguinal) nodes, mesenteric nodes, spleen, liver, and 0.25 ml samples of peripheral blood were 
assayed  for  radioactivity in  a  Picker  Autowell gannna  scintillation spectrometer (Picker 
X-Ray Corp., Cleveland, Ohio).  The ability of the injected lymphoid cells to home to the 
lymph nodes of the recipients was assessed as a  function of the proportion of the injected 
radioactivity lodging in the recipient lymphoid organs. 
Blood  Counts.  Peripheral  leukocytes  from  treated  mice were  counted  in  a  Neubauer 
hemacytometer and  differential counts of  100  cells  were made from Wright-stained blood 
smears. 
RESULTS 
Lymphocytosis.--Either  whole B. pertussis organisms or the supernatants of 
B. pertussis  cultures  (BPCS)  were capable of provoking a brisk leukocytosis, 
beginning  several  hours  after  intravenous  injection,  and  reaching  a  peak 
between 3  and  6  days afterward  (Fig.  1).  If whole  organisms were injected, 
there was  a  marked increase in both lymphocytes and  mature  granulocytes, 
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FIG.  1.  Leukocytosis and  lymphocytosis in mice given B.  pertussi~  whole organisms or 
culture supernatant. Each bar graph represents the mean value obtained from four animals. R.  N.  TAUB,  W.  ROSETT,  A.  ADLER,  AND  S.  I.  MORSE  1583 
while after injection of BPCS lymphocytes predominated,  with  a  lesser incre- 
ment in granulocytes. 
Effects  of In  Vitro  Incubation  of Cr-51-Labeled  Lymph  Node  Cells  with  B. 
pertussis  Culture  Supernatants.--Cr-51-1abeled  lymph  node  cells  were  incu- 
bated for 15 rain at 4°C with BPCS, washed thrice, and injected into syngeneic 
recipients in dosages of 107 cells each. Undiluted BPCS was toxic to lymphocytes 
and ahnost totally inhibited lymphocyte "homing" to lymph nodes or to spleen 
(Table I). BPCS diluted  1 : 10 showed no toxicity by the trypan blue exclusion 
TABLE I 
Effect of In Vitro Incubation with B. pertussis Culture Supernatant Fluids on the Migration of 
Cr-51-Labeled Lymph Node Cells and Thoracic Duct Cells 
Cells  Incubation with 
Percentage of injected radioactivity distributing to:  Cell 
viabil- 
Peripheral  Mesenteric  Spleen  Liver  Blood  ity 
nodes  nodes 
% 
Lymph  Supernatant  0.00"  0.01  9.12  29.69  0.56 
node  (undilute)  (0.02)  (0.02)  (0.88)  (3.00)  (0.04)  75 
Supernatant  0.73  1.76  17.66  21.46  1.59 
(1:10)  (0.07)  (0.31)  (4.08)  (2.22)  (0.14)  95 
Control  4.05  6.63  12.36  17.28  0.76 
(0.46)  (0.96)  (0.95)  (1.50)  (0.06)  95 
Thoracic  Supernatant  0.26:~  0.29  36.03  17.49  6.28 
duct  (1:16)  0.17:~  0.08  39.59  18.71  3.91  81 
Control  3.86  3.96  20.76  11.86  0.66 
3.35  1.55  26.59  12.64  0.93  85 
* Mean 4- (s3) of four animals. 
Values in each of two animals. 
test, yet it was almost as effective in inhibiting migration to lymph nodes. The 
proportion  of cells  migrating  to  the  spleen  was  unaffected,  and  more  of the 
injected  radioactivity  remained  in  the  peripheral  blood.  As  seen  in  Table  I, 
when  thoracic duct lymphocytes were employed in place of lymph node cells, 
incubation with BPCS also markedly inhibited lymphocyte migration. 
Prevention of Lymphocyte Homing in Pertussis-Treated Animals.--Groups  of 
mice were given a  single intravenous injection of 0.2 ml of a  saline suspension 
containing 1 X  109 pertussis organisms or 0.15 ml of undiluted culture superna- 
tant. At various times afterward these mice were challenged intravenously with 
radioactively  labeled  lymphocytes.  Significantly  greater  recovery  of  radio- 
actively  labeled  cells  in  the  blood  was  noted  in  pertussis-treated  animals 1584  DISTRIBUTION  OF LABELED  LYMPHOCYTES 
(Table II). This effect was manifest as early as 1 hr after the injection of whole 
organisms and was present even when  cells were  given 6  days after pertussis 
injection. After injection of whole organisms, there was also usually a decrease 
in the percentage of label found in the mesenteric nodes, whereas there was a 
slight increase in the radioactivity in the spleen. 
When labeled cells were injected into mice which had received BPCS 3 days 
previously, there was not only a higher level of radioactivity in the blood than 
that found in the controls but, in contrast to the findings in mice given whole 
organisms, there was a  marked decrease in the radioactivity recovered in both 
TABLE II 
Distribution  of Cr-5i-Labeled, Normal,  Syngeneic Donor Lymph Node Cells in Mice Treated 
with B. pertussls Organisms or Culture Supernatant 
Treatment 
Interval  WBC at  Percentage of injected radioactivity distributing to: 
before  time of 
injection of  Peripheral  Mesenteric  Spleen 
labeled  cells  sacrifice  Blood  nodes  nodes  Liver 
Intact orga-  1 hr  6,250  1.5"  3.1  4.1  20.7  15.5 
nisms  (0.1)  (0.5)  (0.4)  (1.8)  (1.1) 
1 day  17,600  2.3  3.8  4.6  21.5  14.8 
(0.3)  (0.6)  (0.5)  (2.8)  (0.9) 
3 days  45,400  2.4  3.5  6.0  21.4  16.8 
(0.2)  (0.5)  (1.6)  (1.0)  (1.8) 
6 days  36,500  1.9  3.7  4.3  22.0  16.0 
(0.5)  (0.9)  (0.9)  (1.6)  (1.4) 
Untreated  --  2,500  0.9  3.1  7.3  17.5  17.7 
(0.3)  (1.4)  (1.3)  (4.6)  (5.0) 
Culture super-  3 days  25,300  3.4  3.9  5.8  6.6  18.6 
natant  (0.7)  (0.7)  (0.9)  (1.6)  (1.2) 
Untreated  -  4,100  0.7  6.0  11.9  12.7  15.4 
(0.2)  (0.5)  (1.9)  (1.3)  (1.0) 
* Each value represents the mean  ~= (sD) obtained from four animals. 
the peripheral and mesenteric nodes. Whereas there had been  a  slight increase 
in the quantity of label in the spleen in mice pretreated with whole organisms, 
a  marked decrease was found in BPCS-treated animals. 
Shift of Radioactively Labeled Cells from Lymphoid  Tissues to Blood in Perlus- 
sis-Trealed Recipients.--Groups  of mice were injected intravenously with  1  X 
108 Cr-51-1abeled lymph node cells, and 24 hr later were given either a  dose of 
BPCS  or whole pertussis organisms,  or were  left untreated.  At various times 
afterward  three  mice  from  each  group  were  dissected  and  the  proportion  of 
injected  radioactivity distributing  to  lymphoid  organs  was  determined.  The 
changes in distribution due to pertussis were assessed by determining the ratio 
between  the treated animals and simultaneously sacrificed untreated controls. 
In those animals receiving BPCS there was a clear relative shift of radioactivity R.  N.  TAUB,  W.  ROSETT,  A.  ADLER,  AND  S.  I.  MORSE  1585 
from  lymph  nodes  into  the  blood,  approximating  the  kinetics  of  pertussis- 
induced  lymphocytosis in  these  animals  (Table  III and  Fig.  2).  At the  same 
time  there  was  a  relative  loss of radioactivity in  the  mesenteric  nodes,  small 
intestine,  pooled peripheral  (brachial,  axillary, inguinal)  nodes, and the spleen. 
In animals treated  with whole pertussis  organisms rather than BPCS, there 
was a similar change in the distribution  of labeled cells in the blood and nodes 
as compared with control untreated  animals.  However,  the  spleens  of treated 
mice contained paradoxically more radioactivity than did controls (Table IV). 
TABLE III 
Changes with Time in the Distribution of Cr-51-Labded Lymphoid  Cells in Normal Mice and 
in Mice Injected Intravenously with B. pertussis Culture Supernatant Fluid 24 kr 
after the Injection of Labeled Cells 
Percentage of injected radioactivity distributing to: 
Time after 
pertussis 
supernatant  Blood  Peripheral  Mesenteric 
nodes  nodes  Spleen  Ileum 
1 hr pertussis 
control 
1 day pertus- 
sis control 
3 days pertus- 
sis control 
6 days pertus- 
sis control 
10  days  per- 
tussis  con- 
trol 
1.7  (0.1)* 
1.9  (0.1) 
5.4  (0.7) 
1.5  (0.1) 
3.5  (0.1) 
0.8  (0.1) 
3.3  (0.1) 
1.1  (o.1) 
i 
2.0  (0.4) 
0.6  (0.1) 
3.5  (0.4) 
4.2  (0.3) 
3.5  (0.2) 
3.7  (0.1) 
1.2  (0.1) 
1.7  (0.4) 
1.1  (0.3) 
1.5  (0.1) 
1.0  (0.1) 
2.7  (0.4) 
6.4  (0.3) 
5.9  (0.5) 
3.5  (0.3) 
7.4  (0.6) 
1.4  (0.1) 
3.6  (0.3) 
1.1  (0.3) 
3.3  (0.4) 
1.3  (0.1) 
3.2  (0.8) 
20.8  (0.6) 
19.3  (2.4) 
13.2  (1.7) 
14.0  (0.2) 
8.0  (0.8) 
1.3  (0.4) 
7.9  (2.6) 
10.2  (1.7) 
6.9  (0.1)[ 
12.0  (2.0) 
Liver 
14.7  (1.3) 
15.1  (1.4) 
15.2  (1.5),  2.1 
14.4  (1.6)  3.0 
15.4  (1.4)  1.1 
11.4  (2.8)  2.5 
14.7  (1.2)  1.0 
11.6  (0.6)  1.5 
14.1  (0.8)  0.9 
9.7  (1.0)  1.2 
3.2  (0.4) 
3.9  (0.1) 
(0.1) 
(0.2) 
(o. 1) 
(0.7) 
(o.1) 
(o. 1) 
(o. 1) 
(0.2) 
* Each value represents the mean 4-  (SD) obtained from four animals. 
Secondary  Transfer  of  Cr-51-Labeled  Lymph  Node  Cells from  Normal  or 
Pertussis-Treated  Primary  Recipients.  Groups  of  mice  were  injected  intra- 
venously with  1  )<  108 Cr-51-1abeled  lymph node cells,  and  24 hr later  were 
given pertussis supernatant  intravenously, or were left untreated.  3 days later, 
single-cell suspensions were made from the pooled lymph nodes of each group, 
and  injected  in  doses  of 3  X  l0  s into  groups  of normal  secondary  CBA re- 
cipients.  The  pattern  of distribution  of cells  obtained  from pertussis-treated 
recipients showed some increase in the blood and a decrease in the nodes (Table 
V). 
Distribution  of  Lymphocytes  from  Pertussis-Treated  or  Normal  Donors  in 
Normal  or Pertussis-Treated  Recipients.--In  this  experiment,  an  attempt  was 1586 
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FIG.  2.  Relative shifts of labeled cell activity after pertussis treatment. Each point repre- 
sents: mean radioactivity of pertussis-treated group of three mice X  100; mean radioactivity 
of normal untreated group of three mice for each organ; the values from which this graph is 
derived are given in Table IV. 
TABLE  IV 
Changes ~4th Time in the Distribution of Cr-51-Labeled  Lymph Node Cells in Normal Mice and 
in ~ice injected Intravenously with B. pertussis Organisms 24 hr after Labeled  Cells* 
Percentage of injected radioactivity distributing  to: 
Blood  Peripheral  I  Mesenteric  S"  n  -iver 
nodes  L  nodes  plee  b 
Controls  .  (  .  )  .58  (0.98)6.95  (1.07)10.88  (0.73)12.30  (1.51) 
Ratio  of  pertussis  to  ]3.24  0.63  0.80  1.26  1  00 
control  I 
* The distributions shown were obtained 3 days after the injection of the bacterial cells. 
2~ Each value is the mean 4- (sD) of four animals. R.  N.  TAUB~  W.  ROSETT~  A.  ADLER~  AND  S.  I.  MORSE  1587 
made  to  determine  if  BPCS  acted  only  on  donor  lymphocytes  or  whether 
homing could also be prevented  at the lymph node sites of recirculation  (e.g., 
the  postcapillary endothelium  in small venules)  in recipients  of Cr-51-1abeled 
cells. 
Table  VI  shows  the  distribution  of  lymph  node  cells  taken  from  either 
TABLE V 
Secondary  Transfer  of  Cr-51-Labeled  Lymph  Node  Cells from  Normal  or  Pertussis-Treated 
Primary Recipients 
Cell source 
Pertussis-treated  pri- 
mary recipients 
Normal  primary  re- 
cipients 
Percentage of injected radioactivity distributing to: 
B1 n  [  Peripheral 
,OOu  nodes 
,08 
0.44  (0.24)  6.68  (0.26) 
Mesenteric 
nodes 
13.21  (1.10) 
17.27  (2.14) 
Spleen 
18.27  (1.61) 
18.28  (1 43) 
Liver 
9.17  (0.50) 
8.68  (0.95) 
* Each value represents the mean 4-  (SD) obtained from four animals. 
TABLE VI 
Effects  of B.  pertussis  Culture  Supernatant  Given to  Donors  or  Recipients  of Cr-51-Labeled 
Lymph Node  Cells 
Treatment 
Donor  Recipient 
None  None 
~.  pertus-  None 
sis 
None  B. pertus- 
sis 
B.  pertus-  B. pertus- 
sis  sis 
Percentage of injected radioactivity distributing to: 
Peripheral 
nodes* 
2.48  (0.60)~ 
1.32  (0.01) 
1.19  (0.20) 
1.00  (0.20) 
Mesenterie  Spleen  Liver  Blood 
nodes 
4.71  (0  14)I 8.54  (1.01)  9.89  (0.69)D.05  (0.01 
3.05  (0.04)9.42  (0.26)18.39  (1.65)D.12  (0.01 
2.09  (0.45)15.49  (2.01)10.42  (1.51)0.21  (0.08) 
1.58  (0.04) 11.49  (0.80)  20.25  (1.03)  0.21  (0.08) 
* Pooled brachial, axillary, inguinal. 
:~ Each value is the mean 4- (SD) of four animals. 
normal  or  pertussis-treated  donors  injected  into  normal  or  pertussis-treated 
recipients.  Pertussis-treated  donors and  recipients  had  received  BPCS 4  days 
previously. 
If pertussis had been given to either the donor or the recipient, the migration 
of donor cells  to recipient  lymph nodes was much reduced; more cells  tended 
to stay in the blood. Cells from pertussis-treated  donors, whether injected into 
normal or pertussis-treated  recipients,  showed greater  localization in the liver 
than did cells from normal donors. Cells injected into pertussis-treated  donors 
tended to show increased localization in  the spleen. 1588  DISTRIBUTION O]~  LABELED LYMPHOCYTES 
Effect of In Vitro Incubation of Lymph Node Cells with Plasma from Pertussis- 
Treated Animals.--Plasma was harvested from animals injected 2 hr,  1 day, 3 
days, or 6 days previously with 0.2 ml of B. perlussis supernatant fluid. Cr-51- 
labeled lymph  node  cells were  incubated  for  30  rain  in  plasma from  treated 
animals,  thrice  washed,  and  injected  into  syngeneic  recipients.  A  slight  bt~t 
probably not  significant inhibition of homing  to  mesenteric  nodes was  found 
when cells were incubated with plasma obtained either 2 or 24 hr after injection 
of BPCS. 
Elution of Pertussis from Red Blood Cells and Lymphocytes.--The  aim of this 
experiment was to allow the lymphocytosis-promoting factor of B. pertussis to 
attach to red blood cells of lymphocytes in vitro, wash  the cells several times, 
and determine if activity detached from these cells and re-attached to a  fresh 
inoculum of labeled lymphocytes. The  scheme  of this experiment is shown  in 
Fig. 3.0.5 ml of packed red blood cells or lymph node cells was incubated with 
0.5  m]  0.5  m]  0.5  ml 
Packed R;;C  Packed lymph  Packed lymph 
node cells  node cells 
f  of  1.0  rlll 
Incubate  lO  minutes at  4% 
with  l.O  ml  I/tO0  Pertussis 
Supernatant.  Centrifuge  @ 
I0  minutes at  1,000  rpm 
Supernatant  Supernatant 
+  + 
©  @ 
Resuspend cells  in  5.0  ml  medium, 
centrifuge  lO  minutes,  l,O00  rpm; 
resuspend in  l  ml  fresh  medium, let 
stand  30  minutes;  centrifuge  tO  minutes at  l,O00  rpm 
Supernatant  Supernatant  1.0  ml 
El uate  El uate  Medium 
+  ooi, 
Q  Q 
Resus ~end to  Resus)end  to  vml  @ 
@  @ 
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1 :I00 
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FIG. 3.  Protocol of experiment  on the eIution of B. pertuss@ activity from red blood cells 
and lymph node cells. Add 1 million Cr-51-1abeled cells in 0.5 ml to each lettered tube. Allow 
to incubate 30 min at 4°C, wash once, adjust volume to 3.0 ml, and inject three mice with 
aliquots of 0.5 cc, saving two aliquots for standard samples. R.  N.  TAUB,  W.  ROSETT~  A.  ADLER,  AND  S.  I.  MORSE  1589 
pertussis culture supernatant for 10 min and then washed once with medium. 
The cells were resuspended and allowed to stand in medium for 30 rain and the 
eluate  was  removed  and  tested  for  its  ability to  interact  with  radioactivity 
tagged  lymphocytes  in  vitro  and  prevent  their  later  homing  in  syngeneic 
recipients  (Table  VII).  Packed  red  cells  bound  a  significant  proportion  of 
pertussis  activity,  which  eluted  readily  back  into  fresh  medium.  Packed 
lymph  node  cells absorbed more  of  the  pertussis  activity and  comparatively 
little could  be  eluted  from  the  washed  lymph  node  cells on  incubation  with 
TABLE VII 
Elution of Pertussis from Red Blood Cells or Lymph Node Cells 
Cr-51-1abeled  lymph node cells 
incubated with 
Percentage of injected radioactivity distributing to: 
Pooled lymph  Blood*  nodes~  Spleen  Liver 
Medium only  0.19§  10.36  17.02  9.39 
(0.01)  0.22  0.30  0.70 
1/100 Pertussis  0.40  2.76  22.35  15.28 
supernatant  (0.07)  0.00  1.28  2.14 
Supernatant after absorption  0.52  5.74  22.02  14.53 
by red blood cells  (0.10)  0.58  1.58  1.74 
Supernatant after absorption  0.23  8.86  22.36  15.33 
by lymph node cells  (0.12)  0.86  2.33  0.66 
Eluate from pertussis-treated  0.46  1.88  21.61  13.77 
red blood cells  (0.01)  0.81  1.11  2.57 
Eluate fl om pertussis-treated  0.19  11.73  19.36  13.74 
lymph node cells  (0.03)  0.55  1.55  1.25 
Pertussis-treated red blood  0.51  4.30  23.65  13.70 
cells  (0.05)  0.00  1.42  1.46 
Pertussis-treated lymph  0.47  8.93  21.90  15.37 
node cells  (0.05)  1.00  0.76  3.02 
Normal unlabeled lymph  0.25  12.05  17.45  11.29 
node cells  (0.08)  1.34  2.18  1.48 
* 0.25 ml/mouse. 
Brachial, axillary, inguinal,  mesenteric. 
§ Mean 4- (SD) of four animals. 
fresh medium. Incubation of the treated, washed red blood cells or lymph node 
cells directly with  radioactively labeled  lymphocytes was  sufficient  to  affect 
their ability to home  to the lymph nodes of syngeneic recipients. 
DISCUSSION 
The studies of Gowans and his collaborators established that a  certain sub- 
population  of  lymphocytes  recirculates  from  blood  to  lymph  by  traversing 
specialized endothelium  in  lymph  nodes,  spleen,  and  Peyer's patches  of  the 
ileum (9). Our present data indicate that the lymphocytosis-promoting factor 
(LPF)  elaborated  by  B.  pertussis  acts  to  prevent  lymphocyte  recirculation, 
leading to an accumulation of affected cells in the bloodstream. 1590  DISTRIBUTION  OF  LABELED  LYMPHOCYTES 
Incubation of Cr-51-1abeled  thoracic duct cells or lymph node cells in vitro 
with  BPCS  abrogates  their  capacity  to  migrate  to  lymph  nodes  or  normal 
recipients (Table I). Migration to recipient spleens is less  affected, suggesting 
that  LPF  principally  affects cells  belonging  to  the  lymph  node-seeking  re- 
circulating cell pool. 
Similarly,  if  pertussis  is  administered  to  prospective  recipients  of  Cr-51- 
labeled  mouse  lymphocytes,  the  injected  cells  show  a  markedly  diminished 
arrival  in  recipient  lymph  nodes,  while  more  radioactivity  remains  in  the 
peripheral  blood  (Table II).  Analogous findings  have  been  recorded in mice 
receiving uridinedabeled peripheral lymphocytes (10)  and in LPF-treated rats 
given P-32-1abeled  thoracic duct cells or peripheral leukocytes (11).  In mice, 
these effects are seen after treatment with either B. pertussis whole organisms 
or culture  supernatant;  however,  there  are  differences in  the  distribution  of 
cells after each agent. In animals treated with whole organisms, more injected 
lymphocytes  reach  periperal  nodes  and  the  spleen  than  in  animals  given 
BPCS, although in either case they remain unable to lodge in mesenteric nodes. 
It has been pointed out that whole pertussis organisms should be regarded as a 
mixture  of  antigens,  endotoxins,  and  adjuvants  (12,  13).  It  was  previously 
noted that locally injected pertussis  organisms  affect reticuloendothelial cells 
in draining lymph nodes, causing increased trapping of lymphocytes in lymph- 
oid tissue,  an effect opposite to the lymphocytosis after intravenous adminis- 
tration  (5).  It  may  be  that  intravenously  injected  whole  organisms  simul 
taneously stimulate  lymphocyte trapping  as well  as lymphocytosis, while  the 
supernatant may lack the former activity. 
The  net  effect of  a  decrease  in  homing  of  recirculating  cells  would  be  a 
gradual build-up of these cells in the peripheral blood and their depletion from 
specific  regions of lymph nodes and spleen. This shift of cells was documented 
by our experiments in which animals were equipped with radioactivity labeled 
lymph node cells and injected 24 hr later with B. perlussis (Table III, Fig. 2). 
It  has  been  previously shown  that  only recirculating  lymphocytes lodge  in 
recipient lymph  nodes  (14),  and  that  the  radioactivity declines gradually in 
these cells over a period of 2 wk or longer (8). If decay of the label was assumed 
to  have proceeded equally in both  treated  and  untreated  animals,  then cells 
belonging to the recirculating lymphocyte pool are displaced from lymph nodes, 
small intestine, and spleen into the peripheral blood of pertussis-treated mice. 
This shift of radioactivity is seen  after injection of either B.  perlussis  whole 
organisms or supernatant extract, but is  much tess  striking  after the former. 
Also, after whole 13. pertussis organisms the shift of labeled lymphocytes into 
the blood was accompanied by a paradoxical deposition of cells in the spleen, 
reflecting  the  simultaneous  lymphocytosis  and  lymphocyte  trapping  effects 
(Table IV). 
In order to determine whether the effect of pertussis was exerted on lympho- 
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experiment  was  performed  in  which  cells  from  either  normal  or  pertussis- 
treated donors were given to normal or pertussis-treated recipients. However, 
the  net reduction  in  the  ability of labeled  cells  to reach  the  lymph nodes of 
recipients  was  similar  whether  pertussis  was  given  to  the  donor  or  to  the 
recipient (Table VI). These results are in accord with those reported by Morse 
and Barron  (10).  This suggested that pertussis could act upon either lympho- 
cytes  or  postcapillary  endothelium  to  prevent  lymphocyte  recirculation,  or 
alternatively  that  pertussis  given  to  prospective recipients  of normal  lymph 
node cells is able to attach to the introduced lymphocytes. 
Plasma taken from animals previously injected with pertussis was therefore 
assayed  by  in  vitro  incubation  with  labeled  lymph  node  cells  before  their 
injection into normal recipients. Only miminal pertussis-like activity was found. 
However,  our elution  experiments established  that  pertussis  attaches  loosely 
and  reversibly  to  erythrocytes  and  somewhat  more  firmly  to  lymphocyte 
surfaces.  It  is  retained  in  pharmacologically active  doses  on  red  blood  cells 
in  vitro even after several washings,  and  may elute  rapidly from these  cells 
onto adjacent lymphocytes (Table VII). 
Pertussis lymphocytosis thus appears to be a consequence of the attachment 
of the  active principle  of pertussis  to  surface  sites  on  cells  belonging  to  the 
mobilizable lymphocyte pool.  Cells are likely to be affected while  they are in 
the circulation rather than within  the lymph node parenchyma, and for some 
time after the injection of pertussis cells are prevented from homing back to 
lymphoid tissue and progressively accumulate in the blood. Pertussis is bound 
loosely to red cells,  and may persist as a reservoir on these cells until a lympho- 
cyte is introduced. 
These actions of B. pertussis  organisms or culture supernatants on lympho- 
cytes are sufficient to account for the magnitude and the kinetics of the observed 
lymphocytosis.  It  does  not  seem  necessary  to  invoke  a  separate  action  of 
pertussis on postcapillary endothelium but this cannot be excluded, especially 
since pertussis organisms are known to have other effects on these or adjacent 
structures (5). 
The  thymus  has  been  observed  to  decrease  in  cellularity  during  pertussis 
lymphocytosis (2).  It cannot be told from our data whether there is a  thymic 
contribution  to  the  increase in  cells in  the  peripheral  blood,  or whether  the 
decrease in thymic cellularity reflects an endotoxic action of pertussis such as 
is observed after other endotoxins  (12). 
SUMMARY 
The mechanism by which Bordetella pertussis organisms and  their products 
induce  lymphocytosis in  mice  was  analyzed  in  terms  of  the  localization  of 
syngeneic  Cr-51-1abeled  lymph node  cells.  Labeled  lymphoid cells  incubated 
in vitro with the supernatant of B. pertussis cultures and then injected intra- 
venously into normal recipients, or labeled cells injected into pertussis-treated 1592  DISTRIBUTION  OF  LABELED  LYMPHOCYTES 
recipients were  unable  to  "home"  to  lymphoid organs  but  persisted for long 
periods  in  the  blood.  In  animals  "equipped"  with  a  population  of  Cr-51- 
labeled  lymphoid  cells,  administration  of  B.  perlussis  organisms  or  culture 
supernatant  effected a shift of radioactivity from lymph nodes and spleen into 
the peripheral blood, coincident with the lymphocytosis. 
In in vitro experiments it was found  that  the active principle could bind to 
both erythrocytes and  lymphocytes and  could spontaneously elute from  these 
cells onto labeled lymphocytes which  were then unable  to home  efficiently. 
The data suggest that Bordeldla perlussis-induced  lymphocytosis involves a 
reversible attachment of the pertussis factor onto the surfaces of lymphocytes 
which  prevents their  recirculation to lymphoid organs.  Recirculating lympho- 
cytes are presumably affected as they emerge from  lymphoid organs  to  enter 
the blood. 
Excellent  technical assistance was provided by Mrs.  L. Lawler. 
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